Skip to main content
Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.
All Scholarly Works
  • Sharon Marconi, Baystate Health
  • Christopher Otis, MD, Baystate Health
Document Type
Article, Peer-reviewed
Publication Date
An estrogen receptor-negative variant of the MCF-7 breast cancer cell line, TMX2-28, was used as a model in which to study breast cancer cell invasion. Using a reconstituted basement membrane (Matrigel) assay to evaluate cell invasion, we determined that
Publication ISSN
Citation Information
Mol Cancer Res. 2006 Dec;4(12):905-13.